JP2014501758A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014501758A5 JP2014501758A5 JP2013546071A JP2013546071A JP2014501758A5 JP 2014501758 A5 JP2014501758 A5 JP 2014501758A5 JP 2013546071 A JP2013546071 A JP 2013546071A JP 2013546071 A JP2013546071 A JP 2013546071A JP 2014501758 A5 JP2014501758 A5 JP 2014501758A5
- Authority
- JP
- Japan
- Prior art keywords
- protein
- ligand
- domain
- domains
- asparagine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201061424725P | 2010-12-20 | 2010-12-20 | |
| US61/424,725 | 2010-12-20 | ||
| PCT/SE2011/051536 WO2012087230A1 (en) | 2010-12-20 | 2011-12-19 | Affinity chromatography matrix |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014501758A JP2014501758A (ja) | 2014-01-23 |
| JP2014501758A5 true JP2014501758A5 (enExample) | 2015-02-05 |
| JP5974342B2 JP5974342B2 (ja) | 2016-08-23 |
Family
ID=46314245
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013546071A Active JP5974342B2 (ja) | 2010-12-20 | 2011-12-19 | アフィニティークロマトグラフィーマトリックス |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US9683013B2 (enExample) |
| EP (1) | EP2654915B1 (enExample) |
| JP (1) | JP5974342B2 (enExample) |
| CN (1) | CN103269761B (enExample) |
| WO (1) | WO2012087230A1 (enExample) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG195555A1 (en) | 2008-12-24 | 2013-12-30 | Emd Millipore Corp | Caustic stable chromatography ligands |
| SG10201604559TA (en) | 2011-06-08 | 2016-07-28 | Emd Millipore Corp | Chromatography matrices including novel staphylococcus aureus protein a based ligands |
| US20140221613A1 (en) * | 2011-08-04 | 2014-08-07 | Daicel Corporation | Novel modified protein comprising tandem-type multimer of mutant extracellular domain of protein g |
| US9657055B2 (en) * | 2011-11-30 | 2017-05-23 | Ge Healthcare Bioprocess R&D Ab | Affinity chromatography matrix |
| US10189891B2 (en) * | 2012-03-28 | 2019-01-29 | Ge Healthcare Bioprocess R&D Ab | Affinity chromatography matrix |
| IN2015DN02055A (enExample) | 2012-09-17 | 2015-08-14 | Grace W R & Co | |
| EP3094390B1 (en) | 2014-01-16 | 2021-07-07 | W.R. Grace & CO. - CONN. | Affinity chromatography media and chromatography devices |
| CN104945488B (zh) * | 2014-03-27 | 2020-02-18 | 迈格生物医药（上海）有限公司 | 一种具有免疫球蛋白结合能力的多肽 |
| EP3137209B1 (en) | 2014-05-02 | 2022-10-05 | W.R. Grace & CO. - CONN. | Functionalized support material and methods of making and using functionalized support material |
| US11566082B2 (en) | 2014-11-17 | 2023-01-31 | Cytiva Bioprocess R&D Ab | Mutated immunoglobulin-binding polypeptides |
| WO2016096644A1 (en) * | 2014-12-17 | 2016-06-23 | Ge Healthcare Bioprocess R&D Ab | Modified kappa light chain-binding polypeptides |
| SG10201911134QA (en) | 2015-06-05 | 2020-01-30 | Grace W R & Co | Adsorbent bioprocessing clarification agents and methods of making and using the same |
| GB201515339D0 (en) * | 2015-08-28 | 2015-10-14 | Ge Healthcare Bio Sciences Ab | A seperation matrix and a method of seperating antibodies |
| US10889615B2 (en) | 2016-05-11 | 2021-01-12 | Cytiva Bioprocess R&D Ab | Mutated immunoglobulin-binding polypeptides |
| US10703774B2 (en) | 2016-09-30 | 2020-07-07 | Ge Healthcare Bioprocess R&D Ab | Separation method |
| ES2909833T3 (es) | 2016-05-11 | 2022-05-10 | Cytiva Bioprocess R & D Ab | Método de limpieza y/o desinfección de una matriz de separación |
| JP7106187B2 (ja) | 2016-05-11 | 2022-07-26 | サイティバ・バイオプロセス・アールアンドディ・アクチボラグ | 分離マトリックスを保存する方法 |
| US10654887B2 (en) | 2016-05-11 | 2020-05-19 | Ge Healthcare Bio-Process R&D Ab | Separation matrix |
| ES2874974T3 (es) | 2016-05-11 | 2021-11-05 | Cytiva Bioprocess R & D Ab | Matriz de separación |
| JP7031934B2 (ja) | 2016-05-11 | 2022-03-08 | サイティバ・バイオプロセス・アールアンドディ・アクチボラグ | 分離マトリックス |
| US10730908B2 (en) | 2016-05-11 | 2020-08-04 | Ge Healthcare Bioprocess R&D Ab | Separation method |
| KR101857953B1 (ko) | 2016-07-06 | 2018-05-16 | 아미코젠주식회사 | 알칼리 내성이 증가된 변이 면역글로불린 결합 단백질 |
| GB201615254D0 (en) * | 2016-09-08 | 2016-11-23 | Ge Healthcare Bio Sciences Ab | Novel Ligand and use thereof |
| US12448411B2 (en) | 2016-09-30 | 2025-10-21 | Cytiva Bioprocess R&D Ab | Separation method |
| US11739118B2 (en) | 2017-02-15 | 2023-08-29 | Bioprocessia Technologies Llc | Affinity chromatography ligands with mild elution pH |
| GB201708277D0 (en) | 2017-05-24 | 2017-07-05 | Ge Healthcare | A Recombinant protein |
| EP3875472A1 (en) | 2020-03-06 | 2021-09-08 | Navigo Proteins Gmbh | Novel immunoglobulin binding polypeptides |
| WO2022081779A1 (en) | 2020-10-13 | 2022-04-21 | Avitide LLC | Affinity ligand libraries of three-helix bundle proteins and uses thereof |
| GB202018588D0 (en) | 2020-11-26 | 2021-01-13 | Cytiva Bioprocess R & D Ab | Separation matrix |
| CN117241866A (zh) | 2021-02-19 | 2023-12-15 | 艾维泰有限责任公司 | Aav2亲和剂 |
| GB202113626D0 (en) | 2021-09-24 | 2021-11-10 | Cytiva Bioprocess R & D Ab | FC binding polypeptides |
| WO2026057420A1 (en) | 2024-09-10 | 2026-03-19 | Cytiva Bioprocess R&D Ab | Affinity ligand for purification of antibodies of isotype iga |
| EP4729534A1 (en) | 2024-10-21 | 2026-04-22 | Technische Universität München, in Vertretung des Freistaats Bayern | Polypeptides comprising protein domains linked via rigid amino acid linkers |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE8505922D0 (sv) | 1985-12-13 | 1985-12-13 | Kabigen Ab | Construction of an igg binding protein to facilitate downstream processing using protein engineering |
| US6602977B1 (en) | 1999-04-19 | 2003-08-05 | Biovitrum Ab | Receptor structures |
| US7709209B2 (en) | 2002-03-25 | 2010-05-04 | Ge Healthcare Bio-Sciences Ab | Protein ligands |
| SE0200943D0 (sv) | 2002-03-25 | 2002-03-25 | Amersham Biosciences Ab | Mutant protein |
| EP1641818B1 (en) | 2003-07-04 | 2008-12-03 | Affibody AB | Polypeptides having binding affinity for her2 |
| SE0400274D0 (sv) | 2004-02-09 | 2004-02-09 | Affibody Ab | New polypeptide |
| ATE490268T1 (de) | 2005-03-01 | 2010-12-15 | Affibody Ab | Tnf-alhpa-bindendes polypeptid, anwendungen davon und verfahren, bei denen dieses verwendet wird |
| EP1933883B1 (en) * | 2005-08-03 | 2015-10-07 | Rq Bioscience, Inc. | Methods and compositions for diagnosis of iga-and igm-mediated kidney diseases |
| JP5229888B2 (ja) * | 2008-09-30 | 2013-07-03 | 独立行政法人産業技術総合研究所 | 弱酸性域での易解離性を向上したプロテインａ変異型タンパク質及び抗体捕捉剤 |
| US20120149875A1 (en) | 2009-01-12 | 2012-06-14 | Ge Healthcare Bio-Sciences Ab | Affinity chromatography matrix |
-
2011
- 2011-12-19 US US13/996,023 patent/US9683013B2/en active Active
- 2011-12-19 JP JP2013546071A patent/JP5974342B2/ja active Active
- 2011-12-19 WO PCT/SE2011/051536 patent/WO2012087230A1/en not_active Ceased
- 2011-12-19 CN CN201180061114.1A patent/CN103269761B/zh active Active
- 2011-12-19 EP EP11850413.3A patent/EP2654915B1/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014500311A5 (enExample) | ||
| JP2012515160A5 (enExample) | ||
| JP2014502272A5 (enExample) | ||
| Gaberc‐Porekar et al. | Potential for using histidine tags in purification of proteins at large scale | |
| Zhao et al. | Biomimetic design of affinity peptide ligands for human IgG based on protein A-IgG complex | |
| JP2007252368A5 (enExample) | ||
| JP2019531055A5 (enExample) | ||
| Zachariou et al. | Application of immobilized metal ion chelate complexes as pseudocation exchange adsorbents for protein separation | |
| US20100069617A1 (en) | Enhanced protein aggregate removal by mixed mode chromatography on hydrophobic interaction media in the presence of protein-excluded zwitterions | |
| CN107001432A (zh) | 突变的免疫球蛋白结合多肽 | |
| JP2019034963A (ja) | 陽イオン交換基を用いた新規抗体精製法（Ｎｏｖｅｌ Ａｎｔｉｂｏｄｙ Ｐｕｒｉｆｉｃａｔｉｏｎ ｍｅｔｈｏｄ ｕｓｉｎｇ Ｃａｔｉｏｎ Ｅｘｃｈａｎｇｅｒ） | |
| CN103270044A (zh) | 亲和色谱用载体和分离免疫球蛋白的方法 | |
| JP2016525100A5 (enExample) | ||
| JP2007532477A5 (enExample) | ||
| EP4371996A3 (en) | Methods for purifying antibodies | |
| CN116731129A (zh) | 修饰的κ轻链-结合多肽 | |
| WO2011118599A1 (ja) | アフィニティークロマトグラフィー用充填剤およびイムノグロブリンを単離する方法 | |
| Fan et al. | Polydopamine meets porous membrane: a versatile platform for facile preparation of membrane adsorbers | |
| Nian et al. | Void exclusion of antibodies by grafted-ligand porous particle anion exchangers | |
| RU2014118552A (ru) | Способ выделения фукозилированных антител | |
| CN104603153B (zh) | 用于抗体纯化的载体、其制备方法及其应用 | |
| Scheffel et al. | Optimization of a calcium-dependent Protein A-derived domain for mild antibody purification | |
| JP2015518489A5 (enExample) | ||
| JP2011001336A (ja) | 新規なプロテインａ固定化担体の製造方法 | |
| Opitz et al. | Purification of cell culture-derived influenza virus A/Puerto Rico/8/34 by membrane-based immobilized metal affinity chromatography |